Thrombospondin 1 and cathepsin D improve prostate cancer diagnosis by avoiding potentially unnecessary prostate biopsies

OBJECTIVES: To investigate and further validate if two novel cancer‐related glycoproteins, discovered by a genetic‐guided proteomics approach, can distinguish benign disease from prostate cancer (PCa) in men with enlarged prostates. PATIENTS AND METHODS: A retrospective study was performed that incl...

Descripción completa

Detalles Bibliográficos
Autores principales: Steuber, Thomas, Tennstedt, Pierre, Macagno, Annalisa, Athanasiou, Alcibiade, Wittig, Anja, Huber, Ramy, Golding, Bruno, Schiess, Ralph, Gillessen, Silke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Urological Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379977/
https://www.ncbi.nlm.nih.gov/pubmed/30216634
http://dx.doi.org/10.1111/bju.14540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379977/
https://www.ncbi.nlm.nih.gov/pubmed/30216634
http://dx.doi.org/10.1111/bju.14540

Ejemplares similares